Preliminary Findings on Proline-Rich Protein 14 as a Diagnostic Biomarker for Parkinson’s Disease

The nuclear envelope component proline-rich protein 14 (PRR14) is involved in the nuclear morphological alteration and activation of the mTOR (mammalian target of rapamycin) signaling pathway, and has been repeatedly shown to be upregulated in patients with Parkinson’s disease (PD). The aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Tao, Tan, Xuling, Shi, Xiaoliu, Lv, Lingling, Peng, Xinke, Zhang, Hainan, Tang, Beisha, Wang, Chunyu, Yang, Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128746/
https://www.ncbi.nlm.nih.gov/pubmed/33001354
http://dx.doi.org/10.1007/s12017-020-08617-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128746/
https://www.ncbi.nlm.nih.gov/pubmed/33001354
http://dx.doi.org/10.1007/s12017-020-08617-z

Ejemplares similares